Trial Profile
Prospective cohort study to investigate 2-year visual outcome of a treat and extend protocol involving administration of bevacizumab or ranibizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 12 Dec 2015 New trial record